Josep Tabernero

Josep Tabernero is currently a Scientific Advisor at Merus. Prior to this, they were an Associate Director at Genmab from January 2002 to August 2018. Before that, they were an intern at Leadd B.V. from January 2001 to November 2001.

Josep Tabernero received their PhD in Thesis Epidermal Growth Factor Receptor-targeted Antibody Therapy from Utrecht University. Josep also has a M. Sc. in Medical Biology from University of Amsterdam.